Source: In late January, researchers at BenevolentAI, an artificial intelligence startup in central London, turned their attention to the coronavirus. Within two days, using technologies that can scour scientific literature related to the virus, they pinpointed a possible treatment with speed that surprised both the company that makes the drug and many doctors who Read More

Read More
Artificial Intelligence